idazoxan has been researched along with 4-iodoclonidine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agbaba, D; Filipic, S; Nikolic, K | 1 |
| Agbaba, D; Azzali, E; Costantino, G; Glisic, S; Laurila, JM; Nikolic, K; Perovic, V; Pieroni, M; Radi, M; Scheinin, M; Srdic-Rajic, T; Tassini, S; Veljkovic, N; Vucicevic, J | 1 |
| Haque, M; Kulkarni, RN; MacDermot, J; Olmos, G | 1 |
| Muskardin, DT; Wallace, DR; Zahniser, NR | 1 |
| Piletz, JE; Sletten, K | 1 |
| Ernsberger, P; Shen, IH | 1 |
| Baldwin, J; Chang, CH; Ernsberger, P; Gold, G; Ivanov, TR; Jones, JC; Pickard, RT; Piletz, JE; Reis, DJ; Roth, B; Sharp, JD; Zhu, H | 1 |
7 other study(ies) available for idazoxan and 4-iodoclonidine
| Article | Year |
|---|---|
QSAR study of imidazoline antihypertensive drugs.
Topics: Antihypertensive Agents; Binding Sites; Imidazoline Receptors; Imidazolines; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship | 2008 |
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin.
Topics: Adrenergic alpha-Agonists; Antibiotics, Antineoplastic; Apoptosis; Doxorubicin; Drug Synergism; Humans; K562 Cells; Ligands; Molecular Structure; Oxazoles; Receptors, Adrenergic, alpha-2; Rilmenidine | 2016 |
Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Affinity Labels; Animals; Benzofurans; Binding, Competitive; Clonidine; Clorgyline; Diazoxide; Dioxanes; Guanidines; Idazoxan; Imidazoles; Imidazoline Receptors; Insulin; Insulinoma; Ligands; Pancreatic Neoplasms; Potassium Channels; Rats; Receptors, Drug; Regression Analysis; Software; Tumor Cells, Cultured | 1994 |
Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to alpha 2-adrenoceptors in rat cerebral cortical membranes.
Topics: Adrenergic alpha-Antagonists; Affinity Labels; Animals; Binding, Competitive; Cerebral Cortex; Clonidine; Dioxanes; Idazoxan; Male; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2 | 1994 |
Nonadrenergic imidazoline binding sites on human platelets.
Topics: Affinity Labels; Binding Sites; Binding, Competitive; Blood Platelets; Cell Membrane; Clonidine; Dioxanes; Humans; Idazoxan; Imidazoline Receptors; Iodine Radioisotopes; Kinetics; Norepinephrine; Receptors, Adrenergic, alpha-2; Receptors, Drug; Tritium | 1993 |
Membrane localization and guanine nucleotide sensitivity of medullary I1-imidazoline binding sites.
Topics: Affinity Labels; Animals; Binding Sites; Cattle; Cell Fractionation; Cell Membrane; Clonidine; Guanine Nucleotides; Guanylyl Imidodiphosphate; Idazoxan; Imidazoline Receptors; Medulla Oblongata; Receptors, Drug; Tritium | 1997 |
Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization.
Topics: Amino Acid Motifs; Amino Acid Sequence; Animals; Blotting, Western; CHO Cells; Clonidine; Cloning, Molecular; COS Cells; Cricetinae; DNA, Complementary; Epinephrine; Humans; Idazoxan; Imidazoles; Imidazoline Receptors; Immune Sera; Iodine Radioisotopes; Molecular Sequence Data; Naphazoline; Receptors, Drug; Ruthenium Red; Sequence Tagged Sites; Staining and Labeling; Transfection; Yohimbine | 2000 |